LETROZOLE, EXEMESTANE, ANASTROZOLE, PALBOCICLIB, FULVESTRANT
UC-0140/1615
Phase 3 small_molecule active
Quick answer
LETROZOLE, EXEMESTANE, ANASTROZOLE, PALBOCICLIB, FULVESTRANT for ER+/HER2- metastatic breast cancer is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- ER+/HER2- metastatic breast cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active